Senaste försöken


EudraCT Number: 2004-001054-84 Sponsor Protocol Number: 2004/W/GI/02 Start Date: 2005-02-16
Sponsor Name: NHS Lothian- University Hospitals Division
Full Title: A comparison of the efficacy of dietary hydroxypropylcellulose and questran as therapeutic agents in bile acid induced diarrhoea
Medical condition: these patients will have bile acid induced diarrhoea identified by an increased serum 7a-OH-cholestenone. and will have a history of one of 1. ileal resection 2. idiopathic bile acid diarrhoea.3. ...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results

EudraCT Number: 2004-001854-10 Sponsor Protocol Number: BO18039 Start Date: 2005-02-16
Sponsor Name: F. Hoffmann-La Roche Ltd
Full Title: Randomized, two arm, placebo controlled double dummy study to compare the efficacy of intravenous loading doses followed by maintenance treatment with oral ibandronic acid versus zoledronic acid in...
Medical condition: Metastatic Bone Pain
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) GB (Completed) DE (Prematurely Ended) IT (Prematurely Ended)
Trial results: View results
EudraCT Number: 2004-002453-31 Sponsor Protocol Number: AC-054-201 Start Date: 2005-02-15
Sponsor Name: Actelion Pharmaceuticals Ltd.
Full Title: A Phase IIb, multi-center, international, double-blind, randomized, placebo-controlled, parallel-group, dose-finding study for the prevention of cerebral vasospasm after aneurysmal subarachnoid hem...
Medical condition: Prevention of ischaemic complications related to vasospasm in patients with aneurysmal subarachnoid haemorrhage
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: AT (Completed) SE (Completed) FI (Completed) DE (Completed) IT (Completed) BE (Completed)
Trial results: View results

EudraCT Number: 2004-004633-33 Sponsor Protocol Number: bosex Start Date: 2005-02-15
Sponsor Name: Sexological Clinic, Rigshospitalet
Full Title: local botox administration on patients with vulvar vestbulitis
Medical condition: Vulvar vestibulits
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Female
Trial protocol: DK (Completed)
Trial results: (No results available)
EudraCT Number: 2005-000290-22 Sponsor Protocol Number: Start Date: 2005-02-15
Sponsor Name: TÜ Kardioloogiakliinik
Full Title: Endoteeli funktsiooni hindamiskompleksi (pulsilaine analüüs, koronarograafia, immunohistokeemilised meetodid, biomarkerid) teaduslik väljatöötamine ja juurutamine kliinilises praktikas
Medical condition:
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male
Trial protocol: EE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2005-000040-85 Sponsor Protocol Number: HCC01 Start Date: 2005-02-15
Sponsor Name: Medical School Hannover [...] 1. Medical School Hannover 2. Medical School Hannover
Full Title: Erbitux Monotherapie bei Patienten mit lokoregional nicht behandelbarem Hepatozellulären Karzinom
Medical condition: advanced hepatocellular carcinoma (hcc) not amandable to regional therapies or metastatic disease
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2004-003616-37 Sponsor Protocol Number: M48P3 Start Date: 2005-02-15
Sponsor Name: Chiron Behring GmbH & Co KG
Full Title: M48P3: A phase IV, randomized, controlled, single-blind, multi-center study in children to evaluate the safety, tolerability and immunogenicity of two TBE vaccines administered according to two dif...
Medical condition: TBE prophylaxis
Disease: Version SOC Term Classification Code Term Level
Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results

EudraCT Number: 2004-003945-41 Sponsor Protocol Number: N/A Start Date: 2005-02-15
Sponsor Name: liverpool university
Full Title: Pharmacogenetics of GABAergic mechanisms of benefit and harm in epilepsy: : A prospective cohort study to determine the enviromental and genetic factors associated with response to clobazam.
Medical condition: Epilepsy
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2004-002143-27 Sponsor Protocol Number: 1208.15 Start Date: 2005-02-15
Sponsor Name: Boehringer Ingelheim Austria GmbH
Full Title: A double-blind, stratified, randomised, parallel, placebo-controlled, multi-centre study to compare the efficacy and safety of duloxetine hydrochloride (40mg twice a day) and tolterodine tartrate (...
Medical condition: Urge Urinary Incontinence (UUI)
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Female
Trial protocol: AT (Completed) DK (Prematurely Ended) SE (Completed) DE (Completed)
Trial results: View results

EudraCT Number: 2004-004201-18 Sponsor Protocol Number: 0881A-101696 Start Date: 2005-02-15
Sponsor Name: Wyeth Lederle Nordiska AB
Full Title: A multicenter, open-label, randomized, pilot study to evaluate the efficacy and safety of the combination of etanercept (ETN) and methotrexate and of etanercept (ETN) alone in patients with active ...
Medical condition: Plaque psoriasis
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FI (Completed) DK (Completed) SE (Completed)
Trial results: View results
3
Prenumerera